About N-Zyme

N-Zyme intends to improve the quality of life for millions of people around the globe by developing the first safe, effective and efficient treatment for Laryngopharyngeal Reflux (LPR).

Our Mission

N-Zyme Biomedical seeks to provide a much-needed treatment for the millions of people in the US and worldwide that suffer from LPR.

» What is LPR?
LPR Treatment Research

Our cutting-edge research demonstrates fosamprenavir binds to and inhibits pepsin, preventing pepsin-mediated inflammation and tissue damage.

» Our Research
Excellence in Leadership

Founded by Franco Vigile, an entrepreneur and Nikki Johnston, Ph.D., who dedicated her career to LPR research.

Advisory Board

We bring together industry experts from the business, science and medical communities that are working together to create revolutionary treatments for individuals suffering with reflux disorders such as Laryngopharyngeal Reflux (LPR).

Get Informed

Enter your email to get the latest developments on N-Zyme, including our research, clinical trials and corporate reports.

Thank you for joining us.
Something went wrong. Please contact us on info@nzymebiomedical.com
© 2021 N-Zyme Biomedical Inc.
All Rights Reserved